Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 14 min 58 sec ago

Pay gaps persist for female and African American physicians in US

April 11, 2018 - 3:43pm
(Reuters Health) - Although salaries for U.S. physicians edged higher in 2018, gaps in compensation remained unchanged for females and African Americans, according to Medscape's latest Physician Compensation Report, online April 11.

Costs of 'informal' caregiving for heart disease to reach $128 billion by 2035

April 11, 2018 - 3:33am
(Reuters Health) - As relatives and friends step in to provide increasingly complex care at home for heart attack and stroke survivors, the costs associated with such "informal" caregiving are expected to double to $128 billion by 2035, U.S. heart doctors say.

New device would allow blood-free monitoring of blood sugar levels

April 11, 2018 - 2:29am
(Reuters Health) - A new device applied to the skin could allow people with diabetes to monitor their blood sugar levels without the need for finger sticks or other blood sampling.

When heart disease runs in the family, exercise tied to lower risk

April 11, 2018 - 2:16am
(Reuters Health) - People who get plenty of exercise are less likely to have heart attacks and strokes than their inactive counterparts, even when they have a genetic predisposition for heart disease, a U.K. study suggests.

U.S. death rates falling, but health gains bypassing some states

April 10, 2018 - 11:55pm
(Reuters Health) - Even as U.S. death rates decline, wide variation in life expectancy persists at the state level, a new study shows.

Using transgender youths' chosen names may lower suicide risk

April 10, 2018 - 11:17pm
(Reuters Health) - When a transgender youth chooses a new name, it's important for friends, relatives and acquaintances to use that chosen name, a new study suggests.

New GSK shingles vaccine off to strong start in key U.S. market

April 10, 2018 - 9:28pm
LONDON (Reuters) - GlaxoSmithKline's new shingles vaccine - a priority product as the company strives to improve its drugs line-up - has won more than 90 percent U.S. market share just five months after its launch, prescription-tracking data show.

FDA needs more time to review AbbVie, Neurocrine's uterine pain drug

April 10, 2018 - 8:41pm
(Reuters) - AbbVie Inc and Neurocrine Biosciences Inc said on Tuesday the U.S. Food and Drug Administration notified the companies that it requires more time to review the marketing application for their uterine pain drug.

Mylan to buy MS drug marketing rights from Israel's Mapi Pharma

April 10, 2018 - 7:40pm
(Reuters) - Mylan NV will buy global marketing rights to an experimental multiple sclerosis treatment from Israel's Mapi Pharma, aiming to strengthen its position in the market for MS drugs and counter falling sales of its emergency allergy shot EpiPen.

FDA needs more time to review AbbVie, Neurocrine's uterine pain drug

April 10, 2018 - 6:37pm
(Reuters) - AbbVie Inc and Neurocrine Biosciences Inc said on Tuesday the U.S. Food and Drug Administration notified the companies that it requires more time to review the marketing application for their uterine pain drug.

Loxo, Illumina to partner for diagnostic tool targeting cancer

April 10, 2018 - 5:40pm
(Reuters) - Drug developer Loxo Oncology said on Tuesday it is partnering with genetic testing company Illumina Inc on a diagnostic tool that will work with Loxo's larotrectinib and another one of its experimental cancer drugs, across tumor types.

Mylan to buy marketing rights to MS treatment from Israel's Mapi Pharma

April 10, 2018 - 5:38pm
(Reuters) - Drugmaker Mylan NV is acquiring global marketing rights to an experimental multiple sclerosis treatment from Israel's Mapi Pharma Ltd, the companies said on Tuesday.

Lonza's virus factory shows gene therapy's Texas-sized promise

April 10, 2018 - 3:06pm
ZURICH (Reuters) - Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

Researchers propose new Alzheimer's definition based on biology

April 10, 2018 - 9:32am
(Reuters) - Alzheimer's researchers have proposed a radical change in the way the disease is defined, focusing on biological changes in the body rather than clinical symptoms such as memory loss and cognitive decline.

Trump administration issues rule further watering down Obamacare

April 10, 2018 - 4:29am
WASHINGTON (Reuters) - The Trump administration took additional steps to weaken Obamacare on Monday, allowing U.S. states to relax the rules on what insurers must cover and giving states more power to regulate their individual insurance markets.

Fiery pepper causes 'thunderclap' headache

April 10, 2018 - 4:07am
(Reuters Health) - Eating super-hot chili peppers can have painful effects that extend beyond a blazing mouth, doctors warn.

Cancer drug choices tied to drugmaker payouts to doctors

April 10, 2018 - 3:09am
(Reuters Health) - Some oncologists may be more likely to prescribe certain cancer medicines when they receive payments from the companies that make these drugs, a U.S. study suggests.

Mississippi's last abortion clinic expands lawsuit on restrictions

April 10, 2018 - 2:55am
(Reuters) - Mississippi's last remaining abortion provider expanded a federal challenge on Monday to laws that ban abortions in the state after 15 weeks of pregnancy and block access to the procedure in myriad ways, it said.

Antidepressants in pregnancy tied to changes in babies' brains

April 10, 2018 - 12:53am
(Reuters Health) - Babies' brains may develop differently when their mothers take antidepressants during pregnancy, a small U.S. study suggests.

Few Americans aware of cancer drug shortages

April 10, 2018 - 12:52am
(Reuters Health) - Most Americans aren't aware of cancer drug shortages that might lead some patients to receive less effective or more toxic treatments, a U.S. study suggests.